Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

MBX Biosciences, Inc. MBX

Full chart Compare

Set alert

57.72 USD +1.39 (+2.47%)

At closeNov 12, 2026, 4:03 AM EST

57.97 +0.25 +0.44%

Pre-market · Nov 12, 4:03 AM ET

55.25 Day range 58.56

23.07 52-week range 72.64

YTD: +83.01%
1 year: +134.63%

News

2 days ago globenewswire.com MBX Biosciences Reports Third Quarter 2026 Financial Results and Corporate Highlights Enrollment in pivotal Phase 3 oPTimize trial of once-weekly canvuparatide underway 12-week MAD (Part C, Cohort 1) data for MBX 4291, a GLP-1/GIP co-agonist prodrug for obesity designed for…
1 month ago benzinga.com Stifel Maintains Buy on MBX Biosciences, Raises Price Target to $84 Stifel analyst Annabel Samimy maintains MBX Biosciences (NASDAQ:MBX) with a Buy and raises the price target from $70 to $84.